Skip to content

Clinical trials

Phase 3 Sarcoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Phase: Phase 3 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20102
20112
20141
20151
20172
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1
Unknown status1
Withdrawn1
Recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Advenchen Laboratories, LLC1
Alaunos Therapeutics1
Eisai Inc.1
Eli Lilly and Company1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1
GlaxoSmithKline1
ImmunityBio, Inc.1
Italian Sarcoma Group1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma15
Leiomyosarcoma4
Liposarcoma4
Sarcoma, Synovial3
Endometrial Neoplasms2
Histiocytoma, Malignant Fibrous2
Neoplasm Metastasis2
Ovarian Neoplasms2
Sarcoma, Alveolar Soft Part2
Sarcoma, Endometrial Stromal2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.